At what enterprise value was REVEL acquired in 2022?

You can find the full valuation details of REVEL on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of REVEL when it was acquired by ORADIANSE?

The exact EV/EBITDA multiple for REVEL is available on mynth capital. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

When was REVEL acquired by ORADIANSE?

REVEL was acquired by ORADIANSE in 2022.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the REVEL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the REVEL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://entreprise-decisions.fr/transaction/cabinet-de-radiologie-revel-oradianse/

← DATABASE

Home Database Healthcare & PharmaREVEL

09/2022

REVEL acquired by ORADIANSE

FRANCE Health Providers / Outpatient Care / Radiology REV 1m EUR - 100m EUR

Context

Oradianse, a leading group of radiologists, has acquired a radiology practice in Revel, located in the Haute-Garonne region near Toulouse. This move is part of the company's territorial development strategy, aimed at strengthening its presence in the Occitanie region and consolidating its national network of medical imaging centers. The practice, previously owned by Dr. Gazel since 2019, was seeking a successor to ensure continuity of care for patients in the area as Dr. Gazel prepares for retirement. Through this acquisition, Oradianse is further developing its model of shared medical and technological resources across multiple imaging centers. The integration of the Revel practice is expected to enable the gradual rollout of a teleradiology-based organization, allowing practitioners to remotely access and interpret images from multiple sites within the same geographic area. This approach aims to improve radiologist availability, optimize patient care timelines, and secure the long-term sustainability of imaging services in areas where medical recruitment can be more challenging. By joining Oradianse's national network, the Revel practice will benefit from expanded medical resources, additional investment capacity, and shared organizational tools. As a radiologist-led and owned company, Oradianse is pursuing its growth strategy through targeted acquisitions of independent practices, seeking to preserve local care offerings while developing medical and operational synergies on a national scale. The transaction was advised by the consulting firm Entreprise & Décisions.

REVEL, which reported an EBITDA margin of LOGIN in 2022, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

The Revel Radiology Center is a local medical imaging facility located in the Haute-Garonne region, approximately 50 miles from Toulouse. As the sole imaging center in the Revel catchment area, it serves a population of around 33,000 residents. For several years, the facility has been operated by Dr. Gazel, a radiologist who provides a diverse range of services to meet the everyday diagnostic imaging needs of the local community. The center offers a comprehensive suite of primary care examinations, including conventional radiology, dental imaging, ultrasound, and mammography. It also participates in the national breast cancer screening program, playing a vital role in the prevention and early detection of breast pathologies within its territory. Thanks to this local offering, patients can access diagnostic exams without having to travel to major hospitals or specialized facilities in Toulouse.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2022

2021

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
11/2022	RADNET	HEART & LUNG IMAGING	UNITED KINGDOM	Health Providers	RadNet, a US-based medical imaging specialist, has acquired a 75% majority stake in Heart & Lung Imaging Limited (HLH), a UK-based teleradiology network focused on detecting and diagnosing lung and cardiovascular diseases
10/2022	CBPE CAPITAL	VEINCENTRE	UNITED KINGDOM	Health Providers	CBPE Capital has completed a majority investment in Veincentre, acquiring the stake previously held by Palatine Private Equity alongside the company,s founders. This transaction marks a secondary LBO for the specialist clinic group, which saw significant growth under Palatine,s three-year ownership, including the expansion from 7 to 22 clinics
09/2022	EURAZEO	IMAPOLE	FRANCE	Health Providers	Eurazeo has partnered with Bpifrance to complete a major investment of over EUR 50 million in Imapole. This investment marks a strategic turning point in the professionalization of regional medical imaging groups in France
08/2022	FREEMAN SPOGLI	EVERVET PARTNERS	UNITED STATES	Health Providers	Freeman Spogli & Co. made a significant investment in EverVet Partners, partnering alongside existing investor Tailwind Capital while EverVet's founders and management retained meaningful equity stakes
07/2022	LATOUR CAPITAL	PHARMACIE LAFAYETTE - GROUPE HYGIE31	FRANCE	Health Providers	Latour Capital and Bpifrance acquired a majority stake in Hygie31, the holding company of Pharmacie Lafayette, from Five Arrows (Rothschild & Co). The deal aims to accelerate the group's development in France and Europe through organic growth and an ambitious buy-and-build strategy
07/2022	INFRAVIA CAPITAL	UNIVET	FRANCE	Health Providers	InfraVia Capital Partners acquired a minority stake in Univet from Platina Equity Solutions, which had been a partner since 2018. The transaction was structured as a combination of secondary share purchases and a primary capital increase, financed entirely through equity from InfraVia's EUR5 billion European Fund V
07/2022	ANDERA PARTNERS	GROUPE RESONANCE IMAGERIE	FRANCE	Health Providers	R�sonance Imagerie, a prominent French medical imaging group, has secured a major financing package from Andera MidCap, Ardian Private Debt, and Five Arrows Debt Partners. Established in 2011, the group currently operates a network of 15 centers across Paris, �le-de-France, and the Centre-Val-de-Loire region, managing 23 high-tech units including MRIs and scanners
06/2022	TRITON PARTNERS	ESPERI CARE	FINLAND	Health Providers	Triton Partners, via its Triton Smaller Mid Cap Fund II, acquired a majority stake in Esperi Care Oy from a consortium of its former creditors, including Danske Bank, SEB, and Ilmarinen, which remain as minority shareholders
06/2022	EURAZEO	SEVETYS	FRANCE	Health Providers	Eurazeo acquired a majority stake in Sevetys from Ardian, which had previously financed the group's initial rapid expansion. The transaction included a EUR250 million equity injection from Eurazeo to fuel a new phase of aggressive growth
06/2022	ARDIAN	SIMAGO	FRANCE	Health Providers	Ardian acquired a significant minority stake in Simago. The investment was designed to support the group's rapid "buy-and-build" strategy in a highly fragmented French market. Unlike traditional LBOs, the deal was structured to preserve the medical independence of the associate radiologists, who continue to hold the majority of the capital and voting rights alongside the founding management team

REFERENCES

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of REVEL by ORADIANSE are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: oradianse